Implications of vancomycin-resistant Staphylococcus aureus
- 1 December 1999
- journal article
- Published by Elsevier BV in Journal of Hospital Infection
- Vol. 43, S3-S7
- https://doi.org/10.1016/s0195-6701(99)90060-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Reduced susceptibility to teicoplanin in a methicillin-resistant strain of Staphylococcus aureus.Journal of Antimicrobial Chemotherapy, 1998
- First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospitalThe Lancet, 1998
- Vancomycin-resistant Staphylococcus aureusThe Lancet, 1998
- Vancomycin resistance in staphylococciDrug Resistance Updates, 1998
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Definition of the Clinical Antibacterial Spectrum of ActivityClinical Microbiology & Infection, 1996
- VancomycinMedical Clinics of North America, 1995
- Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPDKidney International, 1993
- Breakpoints in in-vitro antibiotic sesitivity testingJournal of Antimicrobial Chemotherapy, 1988